Rachel Roth Flach

Rachel Roth Flach

Company: Pfizer

Job title: Senior Principal Scientist

Seminars:

Moderated Discussion – What Are the Possible Therapeutic Options for Different Phenotypes? 9:45 am

Read more

day: Day Two

Targeting Peripheral & Cardiac Metabolism for Therapeutic Benefits in Heart Failure 8:45 am

Evaluate how the metabolic HFpEF pheno-group is associated with obesity and diabetes and is increasing in prevalence Discover how metabolic therapies such as exercise have shown benefit in HFpEF across multiple trials Learn how targeting dysregulated branched-chain amino acid metabolism has demonstrated efficacy in preclinical HFpEF modelsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.